Global Breast Lesion Localization Methods Market - Industry Trends and Forecast to 2025

  • Medical Equipment
  • Publish Reports
  • Sep 2017
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220
Global Breast Lesion Localization Methods Market By Type (Wire Localization, Radioisotope Localization, Radioactive Seed Localization, Radio Occult Lesion Localization, Magnetic Tracers, Others), By Biopsy Techniques (Fine Needle Aspiration Biopsy, Core Needle Biopsy, Surgical Biopsy, Incisional Biopsy, Excisional Biopsy, Vacuum-Assisted Breast Biopsy, Others), By End-user (Diagnostic Centres, Hospitals, Oncology Clinics, Ambulatory Surgical Centres), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) - Industry Trends and Forecast to 2025 Global Breast Lesion Localization Methods Market is expected to reach USD 1,367.61 million by 2025 from USD 544.56 million in 2017, at a CAGR of 12.3% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Global Breast Lesion Localization Methods MarketThe major factors contributing to the growth of the market includes factors such as technological advancements in breast localization, rising prevalence of breast cancer and increasing breast cancer surgeries, increasing number of government and non-government reimbursement policies, increasing awareness among people for the diagnosis of breast cancer and innovations of new technologies and methods for breast cancer lesion localization. On the other hand, regulatory scenarios in breast localization and product recall.

Market Segmentation: Global Breast Lesion Localization Methods Market

  • The global breast lesion localization methods market is segmented on the basis of type, biopsy techniques and end user. The report provides data for 2016 to 2025, 2017 being the current year while 2018 to 2025 is the forecast period for the report.
  • The global breast lesion localization market is segmented based on type into wire localization, radioisotope localization, magnetic tracers and others. Global breast lesion localization market is dominated by wire localization with 37.3% market share in 2017, growing at a CAGR of 12.0% in the forecast period. The radioisotope localization is further sub segmented into radioactive seed localization and radio occult lesion localization.
  • The global breast lesion localization market is segmented on the basis of biopsy techniques into fine needle aspiration biopsy, core needle biopsy, surgical biopsy, vacuum-assisted breast biopsy and others. Global breast lesion localization market is dominated by fine needle aspiration biopsy with 32.3% market share in 2017, growing at a CAGR of 12.5% in the forecast period. The surgical biopsy is further sub segmented into incisional biopsy and excisional biopsy.
  • The global breast lesion localization market is segmented on the basis of end user into diagnostic centres, hospitals, oncology clinics and ambulatory surgical centres. Global breast lesion localization market is dominated by hospitals with 35.8% market share in 2017, growing at a CAGR of 12.8% in the forecast period.
  • Based on geography, the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa.

Key Drivers: Global Breast Lesion Localization Methods Market

Some of the major factors driving the market for global breast lesion localization methods market are technological advancements in breast localization, rising prevalence of breast cancer and increasing breast cancer surgeries, increasing number of government and non-government reimbursement policies, increasing awareness among people for the diagnosis of breast cancer and innovations of new technologies and methods for breast cancer lesion localization.

Regulatory scenarios in breast localization and product recall may hinder the growth of the market.

Key Points: Global Breast Lesion Localization Methods Market

ARGON MEDICAL is going to dominate the global breast lesion localization methods market following with Cook Group and C. R. Bard, Inc. Some of the other players are CP Medical, Inc., Cianna Medical, STERYLAB S.r.l., SOMATEX Medical Technologies GmbH, Elucent Medical, Tsunami S.r.l., M.D.L. srl and Biomedical Srl among others.

  • The wire localization segment is dominating the global breast lesion localization methods market. However, magnetic tracers are expected to dominate the global breast lesion localization methods market during the forecast period.
  • The fine needle aspiration biopsy is dominating the breast lesion localization methods market with 32.3% market share, growing at a CAGR 12.5% in the forecast period 2017 to 2024.

SKU-

TABLE OF CONTENTS GLOBAL BREAST LESION LOCALIZATION METHODS MARKET

1. INTRODUCTION

1.1 OVERVIEW OF THE GLOBAL BREAST LESION LOCALIZATION METHODS MARKET 1.2 CURRENCY AND PRICING 1.3 LIMITATION 1.4 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 KEY TAKEAWAYS

2.2 ARRIVING AT THE GLOBAL BREAST LESION LOCALIZATION METHODS MARKET

2.2.1 VENDOR POSITIONING GRID 2.2.2 TECHNOLOGY LIFE LINE CURVE 2.2.3 MARKET TIME LINE 2.2.4 MARKET GUIDE 2.2.5 COMPANY POSITIONING GRID 2.2.6 COMAPANY MARKET SHARE ANALYSIS 2.2.7 MULTIVARIATE MODELLING 2.2.8 STANDARDS OF MEASUREMENT 2.2.9 TOP TO BOTTOM ANALYSIS 2.2.10 VENDOR SHARE ANALYSIS 2.2.11 EPIDEMIOLOGY MODELLING 2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS 2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES

2.3 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET: RESEARCH SNAPSHOT

2.4 ASSUMPTIONS 

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 RISING PREVALENCE OF BREAST CANCER 3.1.2 INCREASING NUMBER OF GOVERNMENT AND NON-GOVERNMENT REIMBURSEMENT POLICIES 3.1.3 INCREASING AWARENESS AMONG PEOPLE TO DIAGNOSIS OF BREAST CANCER

3.2 RESTRAINTS

3.2.1 PRODUCT APPROVAL AND PRODUCT RECALL BY FDA

3.3 OPPORTUNITIES

3.3.1 INNOVATIONS OF NEW TECHNOLOGIES AND METHODS FOR BREAST CANCER LESION LOCALIZATION

3.4 CHALLENGES

3.4.1 RISK ASSOCIATED WITH THE BREAST SURGERY AND PAINFUL CONSEQUENCES

4 EXECUTIVE SUMMARY 5 PREMIUM INSIGHTS 6 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET, BY TYPE

6.1 OVERVIEW 6.2 WIRE LOCALIZATION 6.3 RADIOISOTOPE LOCALIZATION 6.3.1 RADIOACTIVE SEED LOCALIZATION 6.3.2 RADIO OCCULT LESION LOCALIZATION 6.4 MAGNETIC TRACERS 6.5 OTHERS

7 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET, BY BIOPSY TECHNIQUES

7.1 OVERVIEW 7.2 FINE NEEDLE ASPIRATION BIOPSY 7.3 CORE NEEDLE BIOPSY 7.4 SURGICAL BIOPSY 7.4.1 INCISIONAL BIOPSY 7.4.2 EXCISIONAL BIOPSY 7.5 VACUUM-ASSISTED BREAST BIOPSY 7.6 OTHERS

8 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET, BY END USER

8.1 OVERVIEW 8.2 DIAGNOSTIC CENTERS 8.3 HOSPITALS 8.4 ONCOLOGY CLINICS 8.5 AMBULATORY SURGICAL CENTERS

9 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET, BY COUNTRY

9.1 COUNTRY WISE GLOBAL BREAST LESION LOCALIZATION METHODS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

9.1.1 NORTH AMERICA

9.1.1.1 U.S. 9.1.1.2 CANADA 9.1.1.3 MEXICO

9.1.2 EUROPE

9.1.2.1. GERMANY 9.1.2.2 FRANCE 9.1.2.3 U.K. 9.1.2.4 ITALY 9.1.2.5 SPAIN 9.1.2.6 RUSSIA 9.1.2.7 TURKEY 9.1.2.8 BELGIUM 9.1.2.9 NETHERLANDS 9.1.2.10 SWITZERLAND 9.1.2.11 REST OF EUROPE

9.1.3 ASIA-PACIFIC (APAC)

9.1.3.1 JAPAN 9.1.3.2 CHINA 9.1.3.3 SOUTH KOREA 9.1.3.4 INDIA 9.1.3.5 AUSTRALIA 9.1.3.6 SINGAPORE 9.1.3.7 THAILAND 9.1.3.8 MALAYSIA 9.1.3.9 INDONESIA 9.1.3.10 PHILIPPINES 9.1.3.11 REST OF APAC

9.1.4 SOUTH AMERICA

9.1.4.1 BRAZIL 9.1.4.2 REST OF LATIN AMERICA

9.1.5 MIDDLE EAST AND AFRICA

9.1.5.1 SAUDI ARABIA 9.1.5.2 SOUTH AFRICA 9.1.5.3 REST OF MIDDLE EAST AND AFRICA

9.2 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

10 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET: COMPETITIVE LANDSCAPE

10.1. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET: COMPANY SHARE ANALYSIS 10.2. NORTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET: COMPANY SHARE ANALYSIS 10.3. EUROPE BREAST LESION LOCALIZATION METHODS MARKET: COMPANY SHARE ANALYSIS 10.4. ASIA PACIFIC BREAST LESION LOCALIZATION METHODS MARKET: COMPANY SHARE ANALYSIS 10.5. SOUTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET: COMPANY SHARE ANALYSIS 10.6. MIDDLE EAST AND AFRICA BREAST LESION LOCALIZATION METHODS MARKET: COMPANY SHARE ANALYSIS 10.7. MERGERS & ACQUISITIONS 10.8. NEW PRODUCT DEVELOPMENT & APPROVALS 10.9. EXPANSIONS 10.10. REGULATORY CHANGES 10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

11 BREAST LESION LOCALIZATION METHODS MARKET, COMPANY PROFILES

11.1 C. R. BARD, INC.

11.1.1 COMPANY OVERVIEW 11.1.2 FINANCIAL ANALYSIS 11.1.3 PRODUCT MATRIX 11.1.4 RECENT DEVELOPMENTS 11.1.5 DATABRIDGE ANALYSIS

11.2 CP MEDICAL, INC.

10.2.1 COMPANY OVERVIEW 11.2.2 FINANCIAL ANALYSIS 11.2.3 PRODUCT MATRIX 11.2.4 RECENT DEVELOPMENTS 11.2.5 DATABRIDGE ANALYSIS

11.3 CIANNA MEDICAL

11.3.1 COMPANY OVERVIEW 11.3.2 FINANCIAL ANALYSIS 11.3.3 PRODUCT MATRIX 11.3.4 RECENT DEVELOPMENTS 11.3.5 DATABRIDGE ANALYSIS

11.4 COOK

11.4.1 COMPANY OVERVIEW 11.4.2 FINANCIAL ANALYSIS 11.4.3 PRODUCT MATRIX 11.4.4 RECENT DEVELOPMENTS 11.4.5 DATABRIDGE ANALYSIS

11.5 STERYLAB S.R.L.

11.5.1 COMPANY OVERVIEW 11.5.2 FINANCIAL ANALYSIS 11.5.3 PRODUCT MATRIX 11.5.4 RECENT DEVELOPMENTS 11.5.5 DATABRIDGE ANALYSIS

11.6 SOMATEX

11.6.1 COMPANY OVERVIEW 11.6.2 FINANCIAL ANALYSIS 11.6.3 PRODUCT MATRIX 11.6.4 RECENT DEVELOPMENTS 11.6.5 DATABRIDGE ANALYSIS

11.7 ELUCENT MEDICAL

11.7.1 COMPANY OVERVIEW 11.7.2 FINANCIAL ANALYSIS 11.7.3 PRODUCT MATRIX 11.7.4 RECENT DEVELOPMENTS 11.7.5 DATABRIDGE ANALYSIS

11.8 ARGON MEDICAL

11.8.1 COMPANY OVERVIEW 11.8.2 FINANCIAL ANALYSIS 11.8.3 PRODUCT MATRIX 11.8.4 RECENT DEVELOPMENTS 11.8.5 DATABRIDGE ANALYSIS

11.9 TSUNAMI MEDICAL SRL

11.9.1 COMPANY OVERVIEW 11.9.2 FINANCIAL ANALYSIS 11.9.3 PRODUCT MATRIX 11.9.4 RECENT DEVELOPMENTS 11.9.5 DATABRIDGE ANALYSIS

11.10 MDL

11.10.1 COMPANY OVERVIEW 11.10.2 FINANCIAL ANALYSIS 11.10.3 PRODUCT MATRIX 11.10.4 RECENT DEVELOPMENTS 11.10.5 DATABRIDGE ANALYSIS

11.11 BIOMEDICAL SRL

11.11.1 COMPANY OVERVIEW 11.11.2 FINANCIAL ANALYSIS 11.11.3 PRODUCT MATRIX 11.11.4 RECENT DEVELOPMENTS 11.11.5 DATABRIDGE ANALYSIS

11.12 RI.MOS. SRL

11.12.1 COMPANY OVERVIEW 11.12.2 FINANCIAL ANALYSIS 11.12.3 PRODUCT MATRIX 11.12.4 RECENT DEVELOPMENTS 11.12.5 DATABRIDGE ANALYSIS

11.13 LAURANEMEDICAL.COM

11.13.1 COMPANY OVERVIEW 11.13.2 FINANCIAL ANALYSIS 11.13.3 PRODUCT MATRIX 11.13.4 RECENT DEVELOPMENTS 11.13.5 DATABRIDGE ANALYSIS

11.14 BIOPSYBELL SRL

11.14.1 COMPANY OVERVIEW 11.14.2 FINANCIAL ANALYSIS 11.14.3 PRODUCT MATRIX 11.14.4 RECENT DEVELOPMENTS 11.14.5 DATABRIDGE ANALYSIS

12 APPENDIX 13 ABOUT DATA BRIDGE MARKET RESEARCH

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

Please fill in the below form for detailed Inquire Before Buying

Choose License Type
  • $5400.00
  • $4200.00
BUY NOW ADD TO CART